Adva Biotechnology Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
28
- Latest Deal Type
-
Seed
- (In Progress)
- Latest Deal Amount
-
$3M
- Investors
-
3
Adva Biotechnology General Information
Description
Developer of an automated autologous cell manufacturing platform designed to ensure the availability and quality of life-saving advanced therapies. The company's platform is based on a single-use end-to-end system that helps in autologous cell therapy manufacturing at the bedside, allowing optimization, tight quality assurance, improved availability, reduced time to market, and significant cost reduction, enabling patients with life-saving cell therapies.
Contact Information
Website
www.advabio.comCorporate Office
- 3 Hadolev Avenue
- Bar-Lev High-Tech Park
- Ahihud 2015600
- Israel
Corporate Office
- 3 Hadolev Avenue
- Bar-Lev High-Tech Park
- Ahihud 2015600
- Israel
Adva Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Seed Round | 25-Jun-2026 | $3M | In Progress | Generating Revenue/Not Profitable | ||
| 5. Seed Round | 25-Jun-2025 | Completed | Generating Revenue/Not Profitable | |||
| 4. Seed Round | 23-Mar-2021 | Completed | Product Development | |||
| 3. Seed Round | Completed | Product Development | ||||
| 2. Seed Round | $2.64M | $3.26M | Completed | Product Development | ||
| 1. Equity Crowdfunding | 20-Aug-2020 | $615K | $615K | Completed | Generating Revenue |
Adva Biotechnology Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed 2 | ||||||||
| Seed 4 | ||||||||
| Seed 3 | 256,475 | $0.010000 | $10.91 | $10.91 | 1x | $10.91 | 8.72% | |
| Seed 1 | 291,032 | $0.010000 | $9.1 | $9.1 | 1x | $9.1 | 9.88% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Adva Biotechnology Signals
Adva Biotechnology Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| KTS Ventures | Venture Capital | Minority | ||
| Ledgeways Ventures | Venture Capital | Minority | ||
| Sekhmet Ventures | Venture Capital | Minority |
Adva Biotechnology FAQs
-
When was Adva Biotechnology founded?
Adva Biotechnology was founded in 2016.
-
Where is Adva Biotechnology headquartered?
Adva Biotechnology is headquartered in Ahihud, Israel.
-
What is the size of Adva Biotechnology?
Adva Biotechnology has 28 total employees.
-
What industry is Adva Biotechnology in?
Adva Biotechnology’s primary industry is Discovery Tools (Healthcare).
-
Is Adva Biotechnology a private or public company?
Adva Biotechnology is a Private company.
-
What is Adva Biotechnology’s current revenue?
The current revenue for Adva Biotechnology is .
-
How much funding has Adva Biotechnology raised over time?
Adva Biotechnology has raised $25.8M.
-
Who are Adva Biotechnology’s investors?
KTS Ventures, Ledgeways Ventures, and Sekhmet Ventures have invested in Adva Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process